Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Organicell Regenerative Medicine, Inc.

Organicell Announces Matt Sinnreich as CEO
From Organicell Regenerative Medicine, Inc.
Via AccessWire
Topics Derivatives
Exposures Derivatives
Tickers OCEL
Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management
From Organicell Regenerative Medicine, Inc.
Via AccessWire
Exposures COVID-19 Product Safety
Tickers OCEL
Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities
From Organicell Regenerative Medicine, Inc.
Via AccessWire
Tickers OCEL
Organicell Announces Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using ZofinTM
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Launches Autologous Blood Derived Platform PPX™ – Patient Pure X™
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell To Present Results Of Zofin™ Clinical Studies At The International Society Of Cell And Gene Therapy Annual Meeting
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Signs an Exclusive Distribution Agreement with Apex Services in Pakistan
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Begins Up-Listing Process On NASDAQ Exchange
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential
From Organicell Regenerative Medicine, Inc.
Via Business Wire
Tickers OTC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.